SVF INJECTION
/ IV THERAPY

SVF is a mixture of cells extracted from your own fat tissue, and the exact contents depend on how the fat was processed, mechanically broken down, or enzymatically treated, whether cell counts were measured, and whether anything was added during preparation. “Stem cells” is not an accurate or complete description because the mixture contains many cell types, not just stem cells. We explain the specific processing method, what the final product contains, and whether the use is authorized under local regulations before you consent.

The route matters greatly: local injection places the cells where you want improvement. The intended outcome and the evidence supporting it should be matched to the exact route being used, not described generically. Your provider explains which route is planned, what published evidence exists for that route in your treatment area, and what you are and are not being promised.

Fat is harvested through a small liposuction procedure, then processed under sterile conditions using a validated method, with the final product tested or characterized for cell count, viability, and sterility before injection. Every step from harvest to injection should be traceable. We walk through the entire process during your consultation, including how sterility is maintained, so you know what happens between the liposuction and the injection.

Evidence for aesthetic use of SVF remains limited and comes mostly from small studies with varying protocols, so it should not be promised as a proven regenerative treatment on par with standardized medical therapies. The honest answer is that promising early results exist but robust large-scale evidence for most cosmetic claims is still developing. A consultation should include an open discussion of what the data can and cannot support rather than broad promises of rejuvenation.

The regulatory status of SVF therapy varies by country and by how the tissue was processed, and being made from your own cells does not automatically make it exempt from regulation. Some processing methods cross the line from a simple tissue transfer to a manipulated cell product, which may require different authorization. We identify the applicable Korean classification for the exact processing and route being proposed so you know the regulatory framework before you proceed.

The cell count, volume, and whether the product was combined with any additives should be stated clearly before treatment. Manipulated cell products carry different safety and regulatory considerations than minimally processed tissue. Your consent form should list these details rather than using broad terms like “stem cell therapy.”

Expected effects from the fat harvest include bruising, drainage, and firmness at the donor site, while the injection site may be sore and swollen. Fever, chills, rash, shortness of breath, or any neurologic symptom after IV infusion is not routine and requires immediate assessment. We separate expected healing from signs that need urgent attention and give you a written plan for both the donor and recipient sites.

Local injection carries risks of infection, nodules, calcification, and unintended tissue growth at the injection site. IV infusion adds the risk of blood vessel blockage, clotting problems, immune reactions, and contamination reaching the bloodstream. A generic safety discussion is not enough because the hazards depend on the route. Your provider explains the specific risks of your planned route and what early warning signs to watch for.

Active infection, pregnancy, and breastfeeding are clear reasons to defer treatment. A history of cancer, autoimmune disease, bleeding problems, or other serious conditions requires specialist review because the evidence does not define a universally safe candidate. A consultation should include a full medical history review before proceeding.

The number of sessions, the interval between them, and how improvement will be measured should be defined upfront. Subjective satisfaction alone is not enough; your provider should use standardized photos, skin quality measurements, or other objective tools to track change. We agree on these benchmarks before treatment so you and your provider share the same definition of a successful outcome.

There is no well-established universal duration for aesthetic SVF benefits, and claims of how long it lasts should be based on published data rather than clinic experience alone. The absence of short-term problems is not proof of long-term effectiveness. We discuss what the evidence supports and what remains uncertain rather than presenting optimistic estimates as fact.

A written plan should name the receiving hospital, the records supplied, and who is responsible for managing a delayed infection, mass, neurologic event, or systemic illness after international travel. Fever, spreading redness, severe pain, neurologic or visual symptoms, breathing difficulty, or a rapidly growing mass requires urgent medical assessment. We send you home with this plan in writing before your procedure so you are never left guessing about who to call or where to go.